Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$13.4 million.

  • Arcturus Therapeutics Holdings' Income towards Parent Company fell 9481.38% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 656.73%. This contributed to the annual value of -$80.9 million for FY2024, which is 17229.94% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Income towards Parent Company stood at -$13.4 million for Q3 2025, which was down 9481.38% from -$9.2 million recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Income towards Parent Company peaked at $118.6 million during Q4 2022, and registered a low of -$57.7 million during Q1 2021.
  • For the 5-year period, Arcturus Therapeutics Holdings' Income towards Parent Company averaged around -$17.9 million, with its median value being -$21.6 million (2022).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first plummeted by 50944.83% in 2021, then skyrocketed by 41516.0% in 2022.
  • Arcturus Therapeutics Holdings' Income towards Parent Company (Quarter) stood at -$37.6 million in 2021, then skyrocketed by 415.16% to $118.6 million in 2022, then crashed by 109.84% to -$11.7 million in 2023, then tumbled by 156.89% to -$30.0 million in 2024, then skyrocketed by 55.18% to -$13.4 million in 2025.
  • Its last three reported values are -$13.4 million in Q3 2025, -$9.2 million for Q2 2025, and -$14.1 million during Q1 2025.